CYNTHIA HECK: Open Payments
NPI 1659825511 · KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,721 in 60 payments from 9 companies in 2025. Trend: 2023 $1,912 · 2024 $1,450 · 2025 $1,721
Food & beverage: $1,610Education: $111
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 12 | $432 |
| E.R. Squibb & Sons, L.L.C. | 9 | $247 |
| ABBVIE INC. | 18 | $235 |
| Alkermes, Inc. | 5 | $210 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $189 |
| Axsome Therapeutics, Inc. | 4 | $167 |
| Teva Pharmaceuticals USA, Inc. | 5 | $162 |
| Vanda Pharmaceuticals Inc. | 2 | $60 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
Products named: REXULTI, COBENFY, VRAYLAR, CAPLYTA, Auvelity, LYBALVI, ARISTADA, ABILIFY ASIMTUFII.
Industry payments across MO — which companies pay providers there.
